Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)

1.760 +0.010 (+0.57%)

Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Lexicon Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Lexicon Pharmaceuticals Stock Popped by Almost 6% Today ↗

September 28, 2026

An analyst at a prominent research firm initiated coverage of the

Via The Motley Fool

Lexicon Completes SONATA-HCM Enrollment, Eyes 2027 Sotagliflozin Data ↗

September 20, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) said it has completed enrollment in its Phase III SONATA-HCM study of sotagliflozin in hypertrophic cardiomyopathy, with topline data expected in the first quarter...

Via MarketBeat

Lexicon (LXRX) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

SONATA-HCM Phase III enrollment topped 500 patients; data due Q1 2027.

Via The Motley Fool

Topics Earnings

Lexicon Pharmaceuticals Q2 Earnings Call Highlights ↗

August 06, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported a wider second-quarter loss as revenue declined sharply from the prior-year period, while the company highlighted completed enrollment in its Phase III...

Via MarketBeat

Topics Earnings

Lexicon Pharmaceuticals (NASDAQ:LXRX) Falls as Q2 Revenue Misses Estimates ↗

August 06, 2026

Via Chartmill

Lexicon Pharmaceuticals (NASDAQ:LXRX) Scores Perfect 10 Technical Rating After 119% Rally ↗

July 08, 2026

Via Chartmill

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? ↗

June 11, 2026

One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale and steady cash flow. See how their fundamentals stack up.

Via The Motley Fool

Lexicon (LXRX) Q1 2026 Earnings Transcript ↗

June 01, 2026

Lexicon (LXRX) Q1 2026 Earnings Transcript

Via The Motley Fool

Lexicon Pharmaceuticals Q1 Earnings Call Highlights ↗

May 08, 2026

Lexicon Pharmaceuticals (NASDAQ:LXRX) executives highlighted progress across late-stage regulatory programs and efforts to bolster the company’s financial position during the company’s first-quarter...

Via MarketBeat

Topics Earnings

Lexicon Pharmaceuticals (NASDAQ:LXRX) Q1 2026 Results Show Revenue Beat and Narrowed Loss ↗

May 07, 2026

Via Chartmill

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) Beats Q4 Estimates and Strengthens Cash Runway ↗

March 05, 2026

Via Chartmill

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Shows High-Growth Momentum with Strong Technical and Fundamental Trends ↗

January 24, 2026

Via Chartmill

Lexicon (LXRX) Q4 2025 Earnings Call Transcript ↗

March 05, 2026

Lexicon (LXRX) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

December 31, 2025

Via Chartmill

Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 17, 2025

Via Benzinga

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Q3 2025 Earnings Surpass Expectations, Fueling Pre-Market Rally ↗

November 06, 2025

Lexicon Pharmaceuticals (LXRX) Q3 2025 earnings crush estimates with a massive revenue beat, driven by its Novo Nordisk partnership. The stock rose on the strong results and promising pipeline...

Via Chartmill

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 29, 2025

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...

Via Benzinga

Topics Stocks

Lexicon (LXRX) Q2 Revenue Soars 1,706% ↗

August 06, 2025

Via The Motley Fool

Topics Intellectual Property

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Q2 2025 Earnings: Revenue Soars 482% Above Estimates, Stock Gains 9.5% ↗

August 06, 2025

Lexicon Pharmaceuticals (LXRX) reports strong Q2 2025 earnings with $28.9M revenue, beating estimates by 482%. Stock rises 9.5% on profit surprise and pipeline progress.

Via Chartmill

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

A Preview Of Lexicon Pharmaceuticals's Earnings ↗

May 12, 2025

Via Benzinga

Top 2 Health Care Stocks That May Crash This Month ↗

April 25, 2025

Via Benzinga

Curious about the most active stocks on Monday? ↗

March 31, 2025

Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.

Via Chartmill

US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst ↗

March 31, 2025

U.S. stock futures fell on Monday after three consecutive days of decline on Friday. Futures of benchmark indices were lower in premarket.

Via Benzinga

While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60% ↗

March 31, 2025

As uncertainties surrounding trade policies, fresh recession fears, and persistent inflation kept the markets on tenterhooks throughout the past week, a handful of small-caps defied the odds by posting...

Via Benzinga

Topics Economy

Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session. ↗

March 28, 2025

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Friday's session: most active stocks ↗

March 28, 2025

Curious about the most active stocks on Friday? Find out which stocks are dominating the market action!

Via Chartmill

Top movers in Friday's session ↗

March 28, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.